Thierry Bernard

Thierry BERNARD is an experienced executive in the biotechnology and diagnostics fields, currently serving as Chief Executive Officer at QIAGEN since February 2015, while also holding significant board positions at First Light BioSciences, Huttopia & Cie, Daktari Diagnostics, and HepatoChem. BERNARD has a robust background at bioMerieux, where leadership roles included Senior Executive Vice President of worldwide Commercial Operations and Vice President of International Development, managing substantial revenues and operations. BERNARD began a career in management as CEO of ERAI and possesses an extensive educational background from institutions such as Harvard Business School, The London School of Economics, and Sciences Po.